查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1500754

眼保健产品市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033

Eye Health Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球眼科保健产品市场的综合报告。本报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 眼保健产品市场规模（2024年）：28 亿美元
  • 预测市值（2033年）：47 亿美元
  • 全球市场成长率（2024年至2033年年复合成长率）：5.9%

眼部保健品市场-调查范围：

眼科保健产品包括目的是维持和改善视力健康的各种解决方案。其中包括补充剂、药物、视力辅助工具、专为矫正和预防目的而设计的设备等等。该市场为消费者、医疗保健提供者和专业眼保健从业者提供服务，提供适合不同年龄层和特定眼睛状况的产品。

推动市场成长的因素：

全球眼保健产品市场是由多种因素推动的，包括人们对眼睛健康意识的增强、老龄化社会的人口变化以及白内障、黄斑变性和青光眼等眼部疾病患病率的上升等关键因素驱动。眼部护理解决方案的技术进步，包括创新隐形眼镜、手术程序和诊断工具，提高了治疗效果和患者预后。此外，生活方式的改变、城市化和医疗成本的上升也促进了市场的扩张。

市场限制因素：

儘管成长前景广阔，但眼科医疗产品市场面临着监管合规性、产品安全问题和负担能力问题等挑战。管理产品审批和行销的严格监管框架为製造商的市场进入和营运成本设置了障碍。此外，在某些地区，特别是在新兴经济体，有限的保险覆盖范围和眼科护理的自付费用阻碍市场渗透。

市场机会：

眼保健产品市场透过技术创新、消费者教育和策略伙伴关係提供了巨大的成长机会。远距医疗和数位健康平台的进步实现了远端监控和个人化眼科护理服务，提高了患者的可近性和治疗依从性。此外，人工智慧（AI）和机器学习在眼科领域的日益成长的应用促进早期疾病检测和个人化治疗计划，扩大了市场范围。

策略伙伴关係、研发投资以及推出负担得起且易于使用的眼保健解决方案，以利用新机会并在动态的眼科保健领域保持市场领先地位。

本报告涵盖的主要问题

  • 推动全球眼保健产品市场成长的关键因素是什么？
  • 眼保健产品市场中要求最高的细分市场和应用是什么？
  • 科技进步如何改变眼科保健产品市场的竞争格局？
  • 谁是眼保健产品市场的主要参与者？ 他们采取了哪些策略来维持市场地位？
  • 全球眼保健产品市场的新趋势与未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第4章 关键成功因素

  • 产品采用率－关键统计资料
  • 监管场景
  • 疾病流行病学
  • 产品 USP 分析
  • PESTEL 分析
  • 波特的分析

第5章 市场背景

  • 宏观经济因素
  • 预测因子－相关性和影响
  • 市场动态

第6章 COVID-19 危机分析

  • 新冠肺炎（COVID-19）与影响分析
    • 依组件
    • 依适应症
    • 依形式
    • 依地区
  • 2024年市场情景

第7章 全球眼保健产品市场需求分析

  • 2019年至2023年市值历史分析
  • 2024-2033年当前和未来市场价值的分析与预测
    • 年成长趋势分析
    • 绝对的$机会分析

第8章 全球眼保健产品市场分析（依成分）

  • 简介/主要发现
  • 2019年至2023年按成分划分的市场规模过去分析
  • 2024-2033年当前和未来市场规模分析和预测（依成分）
    • 叶黄素和玉米黄素
    • 抗氧化剂
    • Omega-3 脂肪酸
    • 辅酶Q10
    • 类黄酮类化合物
    • 虾红素
    • α-硫辛酸
    • 其他材料
  • 依原料的市场吸引力分析

第9章 全球眼保健产品市场分析（依适应症）

  • 简介/主要发现
  • 过去的市场规模分析（依适应症），2019-2023年
  • 2024-2033年当前和未来市场规模（按适应症）的分析和预测
    • 老年黄斑部病变（AMD）
    • 白内障
    • 干眼症
    • 其他适应症
  • 市场吸引力分析（依适应症）

第10章 全球眼保健产品市场分析（依型态）

  • 简介/主要发现
  • 过去的市场规模分析（依型态），2019-2023年
  • 2024-2033年按型态的当前和未来市场规模的分析和预测
    • 片剂
    • 胶囊
    • 其他
  • 市场吸引力分析（依型态）

第11章 依地区的全球眼保健产品市场分析

  • 简介
  • 过去2019年至2023年依地区的市场规模分析
  • 2024-2033年当前和未来市场价值的分析与预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲（中东、非洲）
  • 区域市场吸引力分析

第12章 北美眼科产品市场分析

第13章 拉丁美洲眼科产品市场分析

第14章 欧洲眼保健品市场分析

第15章 东亚眼科产品市场分析

第16章 南亚眼科产品市场分析

第17章 大洋洲眼科产品市场

第18章 中东与非洲眼科产品市场分析

第19章 市场结构分析

  • 依公司层级的市场分析
  • 主要公司市占率分析
  • 市场现况分析

第20章 竞争分析

  • 竞争对手仪表板
  • 竞争基准
  • 竞争详情
    • Pfizer Inc.
    • The Nature's Bounty Co.
    • Amway International
    • Bausch+Lomb
    • Nutrivein
    • ZeaVision LLC
    • Kemin Industries, Inc.
    • EyeScience
    • Nutrachamps
    • Bausch Health Companies Inc.
    • Vitabiotics Ltd.

第21章 所使用的假设与缩写

第22章 研究方法

简介目录
Product Code: PMRREP5465

Persistence Market Research has recently released a comprehensive report on the worldwide market for eye health products. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Eye Health Products Market Size (2024E): USD 2.8 Billion
  • Projected Market Value (2033F): USD 4.7 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033):5.9%

Eye Health Products Market - Report Scope:

Eye health products encompass a wide range of solutions aimed at maintaining and improving vision health. These include supplements, medications, vision aids, and devices designed for both corrective and preventive purposes. The market caters to consumers, healthcare providers, and specialized eye care professionals, offering products tailored to diverse age groups and specific eye conditions.

Market Growth Drivers:

The global eye health products market is driven by several key factors, including increasing awareness of eye health, demographic shifts towards an aging population, and rising incidences of eye disorders such as cataracts, macular degeneration, and glaucoma. Technological advancements in eye care solutions, including innovative contact lenses, surgical procedures, and diagnostic tools, enhance treatment efficacy and patient outcomes. Moreover, lifestyle changes, urbanization, and greater healthcare expenditures contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the eye health products market faces challenges related to regulatory compliance, product safety concerns, and affordability issues. Stringent regulatory frameworks governing product approval and marketing impose barriers to market entry and operational costs for manufacturers. Additionally, limited insurance coverage and out-of-pocket expenses for eye care treatments in some regions hinder market penetration, particularly in developing economies.

Market Opportunities:

The eye health products market presents significant growth opportunities driven by technological innovations, consumer education, and strategic partnerships. Advances in telemedicine and digital health platforms enable remote monitoring and personalized eye care services, improving patient access and treatment adherence. Furthermore, expanding applications of artificial intelligence (AI) and machine learning in ophthalmology facilitate early disease detection and personalized treatment plans, broadening the market scope.

Strategic partnerships, investment in research and development, and the introduction of affordable, accessible eye health solutions are crucial to capitalize on emerging opportunities and sustain market leadership in the dynamic eye health landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global eye health products market?
  • Which segments and applications within the eye health products market are experiencing the highest demand?
  • How are technological advancements reshaping the competitive landscape of the eye health products market?
  • Who are the key players contributing to the eye health products market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global eye health products market?

Competitive Intelligence and Business Strategy:

Leading players in the global eye health products market, including major pharmaceutical companies, medical device manufacturers, and specialized eye care providers, focus on innovation, research partnerships, and market expansion. These companies invest in developing advanced treatments, novel drug formulations, and patient-centric solutions to address unmet medical needs and enhance vision care outcomes. Collaboration with healthcare providers, patient advocacy groups, and regulatory agencies supports product development and market access, driving technological innovation and market growth in the competitive eye health products landscape.

Key Companies Profiled:

  • The Nature's Bounty Co.
  • Pfizer Inc.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

Key Segments Covered in Eye Health Products Industry Research

Ingredient:

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic Acid
  • Other Ingredients

Indication:

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Other Indications

Form:

  • Tablet
  • Capsule
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmaps
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Rate - Key Statistics
  • 4.2. Regulatory Scenario
  • 4.3. Disease Epidemiology
  • 4.4. Product USP Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Eye Care Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Eye Disorders
    • 5.2.2. Growing Awareness of Eye Diseases
    • 5.2.3. Rising Demand of Eye Health Products Amongst Millennials
    • 5.2.4. Advertisement from Manufacturers
    • 5.2.5. Mergers and Acquisitions
    • 5.2.6. Prevalence of AMD in Elderly Population
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Ingredient
    • 6.1.2. By Indication
    • 6.1.3. By Form
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Eye Health Products Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033, By Ingredient

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Ingredient, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Ingredient, 2024-2033
    • 8.3.1. Lutein and Zeaxanthin
    • 8.3.2. Antioxidants
    • 8.3.3. Omega-3 Fatty Acids
    • 8.3.4. Coenzyme Q10
    • 8.3.5. Flavonoids
    • 8.3.6. Astaxanthin
    • 8.3.7. Alpha-Lipoic Acid
    • 8.3.8. Other Ingredients
  • 8.4. Market Attractiveness Analysis, by Ingredient

9. Global Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Indication, 2024-2033
    • 9.3.1. Age-related Macular Degeneration (AMD)
    • 9.3.2. Cataract
    • 9.3.3. Dry Eye Syndrome
    • 9.3.4. Other Indications
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033, By Form

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Form, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Form, 2024-2033
    • 10.3.1. Tablet
    • 10.3.2. Capsule
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Form

11. Global Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Ingredient
    • 12.3.3. By Indication
    • 12.3.4. By Form
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Ingredient
    • 12.4.3. By Indication
    • 12.4.4. By Form
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Eye Health Products Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Ingredient
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By Form
    • 12.7.2. Canada Eye Health Products Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Ingredient
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By Form

13. Latin America Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Ingredient
    • 13.3.3. By Indication
    • 13.3.4. By Form
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Ingredient
    • 13.4.3. By Indication
    • 13.4.4. By Form
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Eye Health Products Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Ingredient
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By Form
    • 13.7.2. Brazil Eye Health Products Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Ingredient
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By Form
    • 13.7.3. Argentina Eye Health Products Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Ingredient
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By Form

14. Europe Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Ingredient
    • 14.3.3. By Indication
    • 14.3.4. By Form
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Ingredient
    • 14.4.3. By Indication
    • 14.4.4. By Form
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Eye Health Products Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Ingredient
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By Form
    • 14.7.2. Italy Eye Health Products Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Ingredient
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By Form
    • 14.7.3. France Eye Health Products Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Ingredient
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By Form
    • 14.7.4. U.K. Eye Health Products Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Ingredient
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By Form
    • 14.7.5. Spain Eye Health Products Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Ingredient
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By Form
    • 14.7.6. BENELUX Eye Health Products Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Ingredient
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By Form
    • 14.7.7. Russia Eye Health Products Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Ingredient
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By Form

15. East Asia Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Form (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Ingredient
    • 15.3.3. By Indication
    • 15.3.4. By Form
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Ingredient
    • 15.4.2. By Indication
    • 15.4.3. By Form
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Eye Health Products Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Ingredient
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By Form
    • 15.7.2. Japan Eye Health Products Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Ingredient
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By Form
    • 15.7.3. South Korea Eye Health Products Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Ingredient
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By Form

16. South Asia Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Ingredient
    • 16.3.3. By Indication
    • 16.3.4. By Form
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Ingredient
    • 16.4.3. By Indication
    • 16.4.4. By Form
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Eye Health Products Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Ingredient
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By Form
    • 16.7.2. Indonesia Eye Health Products Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Ingredient
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By Form
    • 16.7.3. Malaysia Eye Health Products Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Ingredient
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By Form
    • 16.7.4. Thailand Eye Health Products Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Ingredient
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By Form

17. Oceania Eye Health Products Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Ingredient
    • 17.3.3. By Indication
    • 17.3.4. By Form
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Ingredient
    • 17.4.3. By Indication
    • 17.4.4. By Form
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Eye Health Products Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Ingredient
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By Form
    • 17.7.2. New Zealand Eye Health Products Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Ingredient
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By Form

18. Middle East and Africa (MEA) Eye Health Products Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Ingredient
    • 18.3.3. By Indication
    • 18.3.4. By Form
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Ingredient
    • 18.4.2. By Indication
    • 18.4.3. By Form
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Eye Health Products Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Ingredient
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By Form
    • 18.7.2. Turkey Eye Health Products Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Ingredient
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By Form
    • 18.7.3. South Africa Eye Health Products Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Ingredient
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By Form
    • 18.7.4. North Africa Eye Health Products Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Ingredient
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By Form

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Pfizer Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Ingredient Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Ingredient Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. The Nature's Bounty Co.
      • 20.3.2.1. Overview
      • 20.3.2.2. Ingredient Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Ingredient Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Amway International
      • 20.3.3.1. Overview
      • 20.3.3.2. Ingredient Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Ingredient Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Bausch + Lomb
      • 20.3.4.1. Overview
      • 20.3.4.2. Ingredient Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Ingredient Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Nutrivein
      • 20.3.5.1. Overview
      • 20.3.5.2. Ingredient Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Ingredient Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. ZeaVision LLC
      • 20.3.6.1. Overview
      • 20.3.6.2. Ingredient Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Ingredient Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Kemin Industries, Inc.
      • 20.3.7.1. Overview
      • 20.3.7.2. Ingredient Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Ingredient Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. EyeScience
      • 20.3.8.1. Overview
      • 20.3.8.2. Ingredient Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Ingredient Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Nutrachamps
      • 20.3.9.1. Overview
      • 20.3.9.2. Ingredient Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Ingredient Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Bausch Health Companies Inc.
      • 20.3.10.1. Overview
      • 20.3.10.2. Ingredient Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Ingredient Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Vitabiotics Ltd.
      • 20.3.11.1. Overview
      • 20.3.11.2. Ingredient Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Ingredient Strategy
        • 20.3.11.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology